Posted in | News | Nanobusiness

mPhase to Visit Nanotechnology Research Cluster in Mid-October

mPhase Technologies, Inc. reported today that it is completing arrangements, in cooperation with Invest In France, an agency of the French government, for a second round of meetings at the Grenoble Technology Cluster known as Minalogic.

The Cluster consists of government, corporate and educational members that are engaged in high technology research in the leading scientific disciplines such as micro- and nano-technologies and embedded systems on chips. Minalogic recently received the highest rating for cluster-management excellence from the European Union.

The Company first visited the Cluster in March of 2012 after the relevant agencies reviewed mPhase's patent portfolio and recent valuation. The purpose of the second visit is to continue discussions with potential large strategic partners seeking to use the Company's Smart NanoBattery. It is anticipated that upon the establishment of such a strategic partnership research would continue at one of the Cluster's laboratory facilities at Grenoble, France in conjunction with a strategic sponsoring partner that would target and custom tailor the Company's Smart NanoBattery to be used in a commercial product. All potential strategic partners are currently members of the Cluster.

The scientific focus and interest is based upon the ability of mPhase's Smart Surface technology to electronically control the precise flow of a fluid on a nano-structured surface as well as its potential use of graphene complementing silicon as a material used in the battery for superior conductivity.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.